{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:45:18Z","timestamp":1792514718978,"version":"4.5.0"},"reference-count":41,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"unspecified","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S037306\/1"],"award-info":[{"award-number":["MR\/S037306\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR i4i grant","award":["NIHR204553"],"award-info":[{"award-number":["NIHR204553"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/24\/130031"],"award-info":[{"award-number":["RE\/24\/130031"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/17\/3\/32774"],"award-info":[{"award-number":["RG\/17\/3\/32774"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1136\/openhrt-2026-004443","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:10:24Z","timestamp":1792512624000},"page":"e004443","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: an updated systematic review and meta-analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5554-5293","authenticated-orcid":false,"given":"Fahad","family":"Muhammad","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Jamileh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust, Blackburn, UK"},{"name":"School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Farooq","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust, Blackburn, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abusheikha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Blackpool Victoria Hospital, Blackpool, Lancashire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Department of Cardiology, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abdin","sequence":"additional","affiliation":[{"name":"Saarland University Hospital Internal Medicine III - Cardiology Angiology and Intensive Care Medicine, Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-0671","authenticated-orcid":false,"given":"G Andr\u00e9","family":"Ng","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences Clinical Science Wing, University of Leicester, Leicester, UK"},{"name":"National Institute for Health Research, Leicester Biomedical Research Centre, Leicester, UK"},{"name":"Leicester British Heart Foundation Centre of Research Excellence, Leicester, UK"},{"name":"Department of Cardiology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-7476","authenticated-orcid":false,"given":"Ibrahim","family":"Antoun","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences Clinical Science Wing, University of Leicester, Leicester, UK"},{"name":"Department of Cardiology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102009100993000_13.2.e004443.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac262"},{"key":"2026102009100993000_13.2.e004443.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000549"},{"key":"2026102009100993000_13.2.e004443.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.663807"},{"key":"2026102009100993000_13.2.e004443.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.09.001"},{"key":"2026102009100993000_13.2.e004443.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909545"},{"key":"2026102009100993000_13.2.e004443.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.11.026"},{"key":"2026102009100993000_13.2.e004443.7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or Transvenous Defibrillator Therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"2026102009100993000_13.2.e004443.8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/CIRCULATIONAHA.125.074576","article-title":"Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial","volume":"152","author":"Olde Nordkamp","year":"2025","journal-title":"Circulation"},{"key":"2026102009100993000_13.2.e004443.9","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations\u202f: A Randomized, Multicenter Trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Intern Med"},{"key":"2026102009100993000_13.2.e004443.10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.hrthm.2020.11.013","article-title":"Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis","volume":"18","author":"Rordorf","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026102009100993000_13.2.e004443.11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024756","article-title":"Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies","volume":"11","author":"Fong","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026102009100993000_13.2.e004443.12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2021.11.029","article-title":"Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis","volume":"349","author":"Nso","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026102009100993000_13.2.e004443.13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2025.10.020","article-title":"Inappropriate Shocks From Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: Individual Participant Data Meta-Analysis of Randomized Trials","volume":"87","author":"Benz","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026102009100993000_13.2.e004443.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026102009100993000_13.2.e004443.15","unstructured":"Muhammad F , Jamileh E , Antoun I . Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: an updated systematic review and meta-analysis. PROSPERO. Registration CRD420261328562. 2026."},{"key":"2026102009100993000_13.2.e004443.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026102009100993000_13.2.e004443.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026102009100993000_13.2.e004443.18","unstructured":"Ryan R , Hill S . How to grade the quality of the evidence. Version 3.0. Cochrane Consumers and Communication Group, 2016."},{"key":"2026102009100993000_13.2.e004443.19","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"2026102009100993000_13.2.e004443.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057816"},{"key":"2026102009100993000_13.2.e004443.21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/jce.15080","article-title":"Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: Subcutaneous versus transvenous implantable defibrillator therapy","volume":"32","author":"Palmisano","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026102009100993000_13.2.e004443.22","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"2026102009100993000_13.2.e004443.23","doi-asserted-by":"crossref","unstructured":"Lee C-C , Ho L-T , Lin T-T , et al . Comparison of subcutaneous and transvenous implantable cardioverter-defibrillators: Insights from a single-center cohort in Taiwan. J Formos Med Assoc 2025. doi:10.1016\/j.jfma.2025.06.043","DOI":"10.1016\/j.jfma.2025.06.043"},{"key":"2026102009100993000_13.2.e004443.24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjcn\/zvae067","article-title":"Device-specific quality of life: results from the ATLAS trial-avoid transvenous leads in appropriate subjects","volume":"23","author":"Carroll","year":"2024","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2026102009100993000_13.2.e004443.25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.010822","article-title":"Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial","volume":"17","author":"Knops","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026102009100993000_13.2.e004443.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.698597"},{"key":"2026102009100993000_13.2.e004443.27","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","article-title":"Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases","volume":"149","author":"Baddour","year":"2024","journal-title":"Circulation"},{"key":"2026102009100993000_13.2.e004443.28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/pace.13902","article-title":"Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping","volume":"43","author":"Baddour","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026102009100993000_13.2.e004443.29","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026102009100993000_13.2.e004443.30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"2026102009100993000_13.2.e004443.31","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut370"},{"key":"2026102009100993000_13.2.e004443.32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/CM9.0000000000000133","article-title":"Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators","volume":"132","author":"Liang","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"2026102009100993000_13.2.e004443.33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hrthm.2018.10.026","article-title":"Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation","volume":"16","author":"Viani","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026102009100993000_13.2.e004443.34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2017.11.104","article-title":"Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter-defibrillators","volume":"258","author":"Boveda","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026102009100993000_13.2.e004443.35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eux026","article-title":"Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement","volume":"20","author":"Mithani","year":"2018","journal-title":"Europace"},{"key":"2026102009100993000_13.2.e004443.36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijcard.2016.11.017","article-title":"A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator","volume":"228","author":"Honarbakhsh","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026102009100993000_13.2.e004443.37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14740\/cr638w","article-title":"Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience","volume":"8","author":"Al-Ghamdi","year":"2017","journal-title":"Cardiol Res"},{"key":"2026102009100993000_13.2.e004443.38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00392-016-1055-0","article-title":"Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems","volume":"106","author":"K\u00f6be","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2026102009100993000_13.2.e004443.39","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026102009100993000_13.2.e004443.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.044"},{"key":"2026102009100993000_13.2.e004443.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2012.09.126"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2026-004443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:10:29Z","timestamp":1792512629000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2026-004443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,10,20]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/openhrt-2026-004443"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2026-004443","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}